As a patient in our Center for Young Adult Colorectal Cancer, Lauren has formed a close relationship with her surgeon, Motaz Qadan, MD, PhD, and together they have navigated the impact this disease has had on Lauren.
Motaz Qadan, MD, PhD
Motaz Qadan, MD, PhD
Gapontsev Family Endowed Chair in Surgical Oncology
Associate Professor of Surgery
Departments, Centers, & Programs:
Boston: Massachusetts General Hospital
Mass General Surgery
55 Fruit St.
Boston, MA 02114
- MD, University of Edinburgh
- Residency, Royal Infirmary of Edinburgh
- Residency, Stanford University Hospital and Clinics
- Fellowship, Memorial Sloan Kettering Cancer Center
American Board Certifications
- Complex General Surgical Oncology, American Board of Surgery
- Surgery, American Board of Surgery
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan and introduction of Fingolimod (sphingosine-1-phosphate receptor 1 antagonist) for endothelial barrier disruption in orthotopic pancreatic tumor models.
Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.
Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.
Dr. Qadan is actively involved in many National societies and holds active leadership roles in several organizations. He has over 150 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center.
If you are interested in making a direct donation, please indicate the "Qadan Liver and Pancreas Research Fund". Donations are tax-deductible and handled by my colleague Ms. Meagan Coons of the MGH Development Office, 125 Nashua St, Suite 540, Boston, MA 02114. All donations are so greatly appreciated.
Related News and Articles
- Clinician Resource
- May | 17 | 2021
The Department of Surgery Resident Wellbeing Council exists to support all residents—junior and senior—in achieving optimal mental well-being during their training at Mass General and beyond.
- May | 4 | 2020
Dr. Hong and Dr. Qadan discuss how the Cancer Center has had to postpone some cancer surgeries due to the COVID-19 pandemic, how these patients are being managed and how the Cancer Center is prioritizing each and every patient going forward.